Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
J Org Chem ; 89(9): 6474-6488, 2024 May 03.
Article in English | MEDLINE | ID: mdl-38607334

ABSTRACT

We report a step-economic strategy for the direct synthesis of spiro polycyclic N-heterocycles and indolecarbazole-fused naphthoquinones by merging oxidative coupling and cascade palladium-catalyzed intramolecular oxidative cyclization. In the protocol, bi-indolylnaphthoquinones were first synthesized by oxidative coupling of indoles and naphthoquinones. Subsequent cascade palladium-catalyzed intramolecular oxidative cyclization of bi-indolylnaphthoquinones gave spiro polycyclic N-heterocycles and indolecarbazoles. The intramolecular oxidative cyclization approach could also be realized by the presence or absence of iron catalysts under standard conditions. This protocol is featured with moderate to excellent yields, a wide substrate scope, and divergent structures of products.

2.
Acta Pharmaceutica Sinica ; (12): 231-241, 2009.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-278275

ABSTRACT

Inflammatory diseases are common medical conditions seen in disorders of human immune system. There is a great demand for anti-inflammatory drugs. There are major inflammatory mediators in arachidonic acid metabolic network. Several enzymes in this network have been used as key targets for the development of anti-inflammatory drugs. However, specific single-target inhibitors can not sufficiently control the network balance and may cause side effects at the same time. Most inflammation induced diseases come from the complicated coupling of inflammatory cascades involving multiple targets. In order to treat these complicated diseases, drugs that can intervene multi-targets at the same time attracted much attention. The goal of this review is mainly focused on the key enzymes in arachidonic acid metabolic network, such as phospholipase A2, cyclooxygenase, 5-lipoxygenase and eukotriene A4 hydrolase. Advance in single target and multi-targe inhibitors is summarized.


Subject(s)
Animals , Humans , Anti-Inflammatory Agents , Therapeutic Uses , Arachidonate 5-Lipoxygenase , Metabolism , Therapeutic Uses , Arachidonic Acid , Metabolism , Cyclooxygenase Inhibitors , Therapeutic Uses , Drug Delivery Systems , Methods , Epoxide Hydrolases , Metabolism , Therapeutic Uses , Inflammation , Drug Therapy , Lipoxygenase Inhibitors , Metabolic Networks and Pathways , Phospholipase A2 Inhibitors , Phospholipases A2 , Metabolism , Therapeutic Uses , Prostaglandin-Endoperoxide Synthases , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...